SCHEMBL3137745

SCHEMBL3137745

CNc1cc2cc(C(=O)O)ccc2n1C

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.46
ALDH1A1 P00352 5/20 0.43
HSD17B10 Q99714 4/20 0.43
HCAR3 P49019 4/20 0.43
HPGD P15428 3/20 0.43
MCL1 Q07820 2/20 0.43
PHGDH O43175 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
RXRA P19793 1/20 0.40
GLA P06280 1/20 0.39
BRD4 O60885 1/20 0.38
BRPF1 P55201 1/20 0.38
RAPGEF4 Q8WZA2 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1339692 0.84 L3MBTL1 (0.49) KDM4EALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL5889548 0.78 KDM4E (0.68) KDM4EALDH1A1HSD17B10HCAR3HPGD
SCHEMBL30622485 0.78 KDM4E (0.55) KDM4EALDH1A1HSD17B10HCAR3HPGD
SCHEMBL3987986 0.78 KDM4E (0.55) KDM4EALDH1A1HSD17B10HCAR3HPGD
SCHEMBL28264561 0.77 MCL1 (0.53) KDM4EALDH1A1HSD17B10HCAR3HPGD
SCHEMBL28143548 0.77 KDM4E (0.49) KDM4EALDH1A1HSD17B10HCAR3HPGD
SCHEMBL27880258 0.77 KDM4E (0.53) KDM4EALDH1A1HSD17B10HCAR3HPGD
SCHEMBL28323883 0.77 HCAR3 (0.49) KDM4EALDH1A1HSD17B10HCAR3HPGD
SCHEMBL408368 0.75 KDM4E (0.47) KDM4EALDH1A1HSD17B10HCAR3HPGD
SCHEMBL16441004 0.74 KDM4E (0.46) KDM4EALDH1A1HSD17B10HCAR3HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940840-B1 6-HETEROARYLPYRIDOINDOLONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2010-07-21 EP disclosed
EP-1742947-B1 6-SUBSTITUTED PYRIDOINDOLONE DERIVATIVES PRODUCTION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2008-08-20 EP disclosed
EP-1940840-A1 6-HETEROARYLPYRIDOINDOLONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2008-07-09 EP disclosed
EP-1556382-B1 3-PHENYL SUBSTITUTED PYRIDOINDOLONE, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2008-05-28 EP disclosed
WO-2007045758-A1 6-HETEROARYLPYRIDOINDOLONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2007-04-26 WO disclosed
EP-1742947-A1 6-SUBSTITUTED PYRIDOINDOLONE DERIVATIVES PRODUCTION AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2007-01-17 EP disclosed
WO-2005108398-A1 6-SUBSTITUTED PYRIDOINDOLONE DERIVATIVES PRODUCTION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2005-11-17 WO disclosed
EP-1556382-A1 3-PHENYL SUBSTITUTED PYRIDOINDOLONE, PREPARATION AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2005-07-27 EP disclosed
WO-2004041817-A1 3-PHENYL SUBSTITUTED PYRIDOINDOLONE, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2004-05-21 WO disclosed